Satellite Banner
Technology Networks Header
Tuesday, July 29, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Shimadzu Releases QuantAnalyticsTM Open Access LCMS Software Package for Clinical Applications
Monday, June 16, 2014
The software increases the speed and efficiency of data processing and review by allowing users to highlight and review results that are of specific importance to clinicians.

SciGene Introduces New Rapid FISH Hybridizer
Friday, June 13, 2014
CytoBrite Slide Incubation System detects slide conditions using SlideSense™ technology.

Quest Diagnostics Introduces bioMerieux THxID®-BRAF Test
Wednesday, June 11, 2014
A companion diagnostic to advance precision medicine for melanoma.

New AQUIOS CL Clinical Cytometer* For Routine Applications in Clinical Lab
Tuesday, June 10, 2014
The fully automated instrument delivers fast, efficient results.

Randox Adiponectin Assay Gains CE Approval
Thursday, June 05, 2014
The Company’s technology has brought a superior option for Adiponectin assessment to the clinical diagnostics market.

Multiplicom Launches Two New Diagnostic Kits
Tuesday, June 03, 2014
Company aims for strong growth in the rapidly expanding molecular diagnostic market.

New Cancer Diagnostic Device
Thursday, May 29, 2014
Commercial launch of a new system to improve cancer diagnosis and treatment.

New Refrigerated Small Benchtop Centrifuge from Thermo Fisher Scientific
Thursday, May 22, 2014
Optimizing throughput, time and lab space for life science researchers and clinical laboratories.

Bio-Rad Expands Portfolio of PrimePCR™ Assays for Droplet Digital™ PCR
Wednesday, May 21, 2014
Company expands its collection of validated assays for mutation detection and copy number variation.

<< 1 2 3 4 5 6 7 >>
Showing Results 21 - 30 of 443
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv